Navigation Links
Women With Breast Cancer Can Now USE IVF To Spare Their Daughters

Women with a family history of breast cancer could be allowed to use IVF to have children free of the disease. These new proposals that is due to be discussed by the government's fertility watchdog tomorrow for approval. // WOMEN with inherited forms of breast cancer will be allowed to select embryos free from genes that can cause the disease.

This landmark ruling from the Human Fertilisation and Embryology Authority (HFEA) would permit thousands of women who carry the BRCA1 and BRCA2 genes to spare their daughters a genetic inheritance that confers an 80 per cent lifetime risk of developing breast cancer. The move, which also applies to a third gene that predisposes to bowel cancer, has also won the backing of the watchdog’s ethics and law committee, and is expected to be confirmed at a meeting in Belfast.

People who know that they have the BRCA1, BRCA2 or HNPCC colon cancer genes will be able to seek IVF treatment, during which a single cell is removed from the embryos for testing. Then only the embryos without those genes would be used for fertility.

This decision is expected to deepen the already existing controversy over “designer babies”, as it now significantly extends over the inherited conditions that can be prevented by “cherry-picking” the embryos. The screening procedure, known as pre-implantation genetic diagnosis (PGD), is at present approved only for mutations that lead to at least a 90 per cent chance of developing a disease.

The genes that are covered by the recommendations carry a lifetime cancer risk of 80%, which can be substantially reduced by preventive surgeries like double mastectomy, that is chosen by many women who test positive for BRCA1 or BRCA2.

Many critics feel that the move has marked a further step down a “slippery slope”, which was permitting screening for ever less serious genetic traits. Patient groups, however, welcomed the recommendation as a measure that would help fami lies that have suffered genetic disease in several generations. Expecting the first application for a licence to perform PGD for breast cancer, Paul Serhal, of University College Hospital in London, has already seen ten patients with BRCA genes who want the procedure, and other clinics are also ready to conduct it.

The Times had in 2004 disclosed that Mr Serhal had won the first HFEA licence to screen embryos for a form of bowel tumour that affects 90% of those who inherit the gene. He has also received a licence to screen for the eye cancer retinoblastoma. He said that it would be hard for the HFEA to justify refusing permission to screen for the BRCA and HNPCC genes, given its earlier decisions. He explained that this procedure has the potential to reduce the incidence of serious diseases and also reduce the costs as far as ongoing medical care is concerned.

Extending this to look for the breast cancer genes would be a significant step for three reasons. First the genes are not an automatic death sentence: each results in an 80% risk of developing breast cancer. But unlike cystic fibrosis, breast cancer is treatable and can be prevented by mastectomy. And it kills much later - in a woman's 30s or 40s - so an embryo that is destroyed might have lived until then.

Stating that medicine is about caring not about killing, Josephine Qintavalle of the lobby group Comment on Reproductive Ethics, which opposes all uses of PGD stated that the right approach would be to learn more about the cancer and how to curing it.

The fertility doctors were quick to disagree. Simon Fishel, managing director of CARE, a group of fertility clinics stated that if families would wish to eliminate the threat of serious cancer from their family they should be at liberty to do so. Joan Finlayson, 47, from Arbroath, who finished nine months of excruciating treatment in September involving chemotherapy, radiotherapy and surgery. She stated that she w ould do absolutely anything to prevent her daughter from having to go through what she went through.

'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Mass. , Oct. 4, 2017  According to the Centers for ... the end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the ... as mandated by certain health insurance regulations. ... The best time to get a flu shot is by the ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology: